HIGHLIGHTS
- who: News et al. from the State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University and School of Life Sciences, Nanjing University, Nanjing, China have published the paper: Flagellated bacterial porter for in situ tumor vaccine, in the Journal: (JOURNAL)
- what: The expression or dysfunction of immune checkpoints is one of the important reasons for the occurrence of many diseases.
- how: The results showed that compared with the control group (mPEG modification to shield the charge and no PAMAM modification) the number and types of antigens captured by the positively charged . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.